EFFECT OF L-CARNITINE AND ACYLCARNITINE DERIVATIVES ON THE PROLIFERATION AND MONOCLONAL-ANTIBODY PRODUCTION OF MOUSE HYBRIDOMA CELLS IN CULTURE

被引:9
作者
BERCHICHE, L
LEGRAND, C
CAPIAUMONT, J
BELLEVILLE, F
NABET, P
机构
[1] MED SCH VANDOEUVRE,MED BIOCHEM LAB 1,F-54505 VANDOEUVRE NANCY,FRANCE
[2] IBN,F-54505 VANDOEUVRE NANCY,FRANCE
关键词
L-CARNITINE; MONOCLONAL ANTIBODY; CELL CULTURE; AMINO ACID METABOLISM;
D O I
10.1016/0168-1656(94)90087-6
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The effect of L-carnitine (Cn) on cell growth metabolism and antibody production rates was investigated using the murine hybridoma cell line, Mark3, in batch and fed harvest cultures. Two acylcarnitine derivatives were also tested: palmitoyl L-Cn and acetyl-DL-Cn. The addition of 20 mu M L-Cn to cultures of Mark3 hybridoma cells that had been adapted to L-Cn significantly stimulated monoclonal antibody (mAb) production without affecting cell growth. In contrast, mAb secretion slightly decreased when L-Cn was added to culture of cells that had not been adapted to L-Cn. Palmitoyl L-Cn also stimulated mAb production by adapted cells, whereas the acetyl-DL-Cn, reduced mAb secretion. The presence of L-Cn in the medium did not affect glucose consumption or lactate production, but the metabolism of some amino acids was altered. The medium concentrations of valine, leucine, isoleucine and lysine were enhanced from 22% to 41% according to amino acids, whereas those of alanine, glycine and proline decreased. The mechanism by which L-carnitine affects mAb production and the metabolism of some amino acids is unknown. This effect is likely to be indirect, since there was no net entry of L-[H-3]carnitine into the cells.
引用
收藏
页码:175 / 183
页数:9
相关论文
共 33 条
[1]   CLINICAL-VARIETIES OF CARNITINE AND CARNITINE PALMITOYLTRANSFERASE DEFICIENCY [J].
ANGELINI, C ;
TREVISAN, C ;
ISAYA, G ;
PEGOLO, G ;
VERGANI, L .
CLINICAL BIOCHEMISTRY, 1987, 20 (01) :1-7
[2]  
ARDUINI A, 1992, BIOCHEM BIOPH RES CO, V187, P53
[3]  
BORUM PR, 1987, LIPIDS MODERN NUTR, P51
[4]   MONOCLONAL-ANTIBODIES INTO THE 90S - THE ALL-PURPOSE TOOL [J].
CARLSSON, R ;
GLAD, C ;
BORREBAECK, CKA .
BIO-TECHNOLOGY, 1989, 7 (06) :567-&
[5]  
CEDERBLAD G, 1976, SCAND J CLIN LAB INV, V36, P542
[6]   DETERMINATION OF SPECIFIC MONOCLONAL-ANTIBODY SECRETION RATE DURING VERY SLOW HYBRIDOMA GROWTH [J].
FLICKINGER, MC ;
GOEBEL, NK ;
BOHN, MA .
BIOPROCESS ENGINEERING, 1990, 5 (04) :155-164
[7]  
GELOT MA, 1990, ANN BIOL CLIN-PARIS, V48, P182
[8]   CARNITINE TRANSPORT IN HUMAN INTESTINAL BIOPSY SPECIMENS - DEMONSTRATION OF AN ACTIVE-TRANSPORT SYSTEM [J].
HAMILTON, JW ;
LI, BUK ;
SHUG, AL ;
OLSEN, WA .
GASTROENTEROLOGY, 1986, 91 (01) :10-16
[9]  
JACOB JL, 1992, ANN BIOL CLIN-PARIS, V50, P723
[10]   NEW STRATEGIES FOR THE DESIGN OF CATALYTIC ANTIBODIES [J].
JANDA, KD .
BIOTECHNOLOGY PROGRESS, 1990, 6 (03) :178-181